ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

2019 ACR/ARP Annual Meeting

November 8-13, 2019. Atlanta, GA.

View by Number View by Title View Sessions
View by Date

Tuesday, November 12, 2019

9:00AM-11:00AM
Abstract Number: 2055
High Dietary Sodium Intake May Be Associated with Symptomatic Knee Osteoarthritis in a Korean Population: Korean National Health and Nutrition Examination Survey, 2010-2011
Epidemiology & Public Health Poster III: OA, Gout, & Other Diseases
9:00AM-11:00AM
Abstract Number: 2379
High Initial Methotrexate Dose Is Not Associated with an Increased Risk of Liver Toxicity in Korean Patients with Rheumatoid Arthritis
RA – Treatments Poster III: Safety and Outcomes
9:00AM-11:00AM
Abstract Number: 2325
High Intensity Interval Training Improves Rheumatoid Arthritis Cardiorespiratory Fitness and Systemic Inflammation in Association with Alterations in Skeletal Muscle Metabolomic Profiles
RA – Diagnosis, Manifestations, & Outcomes Poster III: Comorbidities
9:00AM-11:00AM
Abstract Number: 2180
High Molecular Weight Intraarticular Hyaluronic Acid for the Treatment of Knee Osteoarthritis: A Network Meta-Analysis
Osteoarthritis – Clinical Poster II
9:00AM-11:00AM
Abstract Number: 2039
High Prevalence and Disease Correlation of Autoantibodies Against p40 Encoded by Long Interspersed Nuclear Elements (LINE-1) in SLE
SLE – Etiology & Pathogenesis Poster II
9:00AM-11:00AM
Abstract Number: 2021
Higher Genetic Risk Load in Patients with More Diverse Manifestations in a Korean Systemic Lupus Erythematosus Cohort
SLE – Etiology & Pathogenesis Poster II
9:00AM-11:00AM
Abstract Number: 2285
Higher Than Expected Rates of Adverse Pregnancy Outcomes in Patients with Systemic Lupus Erythematosus from Three Tertiary Care Centers
Reproductive Issues In Rheumatic Disorders Poster
9:00AM-11:00AM
Abstract Number: 2233
Hip Fracture Incidence in a Teaching Hospital: Intervention for the Prevention of Second Hip Fracture
Osteoporosis & Metabolic Bone Disease – Basic & Clinical Science Poster
9:00AM-11:00AM
Abstract Number: 1997
Histologic and Clinical Correlates of Ultrasound Measures of Joint Inflammation: Analysis of RA Tissue Obtained by Ultrasound Guided Biopsy in Phase 2 of the Accelerating Medicines Partnership RA Network
RA – Etiology & Pathogenesis Poster II
9:00AM-11:00AM
Abstract Number: 2556
Histologic Findings from Paired Renal Biopsies and Clinical Outcomes: Results from a Single Site in the Phase III Study of Abatacept in Patients with Proliferative LN
SLE – Clinical Poster III: Treatment
9:00AM-11:00AM
Abstract Number: 2008
Histone Lysine Methyltransferase MLL1 Regulates the Expression of Cytokines and Chemokines in Rheumatoid Arthritis Synovial Fibroblasts
RA – Etiology & Pathogenesis Poster II
9:00AM-11:00AM
Abstract Number: 2591
Hospitalization Among Incident Cases of Systemic Sclerosis: Results from a Population-based Cohort (1980-2016)
Systemic Sclerosis & Related Disorders – Clinical Poster III
9:00AM-11:00AM
Abstract Number: 2121
Hospitalization Trends for Bacterial Septic Arthritis in the United States from 1997 to 2014
Infection-Related Rheumatic Disease Poster
9:00AM-11:00AM
Abstract Number: 2613
Hsp90 as a Potential Biomarker of Lung and Skin Involvement in Patients with Systemic Sclerosis
Systemic Sclerosis & Related Disorders – Clinical Poster III
9:00AM-11:00AM
Abstract Number: 1978
HSP90AA1, a Chaperone-mediated Autophagy Mediator, Is a Biomarker of Joint Damage in Osteoarthritis
Osteoarthritis & Joint Biology – Basic Science Poster
  • «Previous Page
  • 1
  • …
  • 22
  • 23
  • 24
  • 25
  • 26
  • …
  • 64
  • Next Page»
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology